Dr KK Aggarwal
President CMAAO, HCFI and Past
National President IMA
Summary
7th Feb Friday observe as National Wear Red Day, continue asking
patients with suspected flu or diarrhoea if they, or someone they have been in
contact with, recently returned from China affected area. Corona is a Public
Health Emergency of International Concern as person-to-person transmission in
UK, USA, Germany, Japan, Taiwan and Vietnam an( mandatory to report to WHO
human and animal cases), d a death in the Philippines on Feb2 marks the first
death of 44 M occurring outside of
China.
The virus behaves
like SARS with 2 % case fatality (15% of admitted cases), time to death 14 days, 3-4 reproductive number R0, has its origin
from bats, spreads like large droplets and predominately from people having
lower respiratory infections and hence universal droplet precautions the
answer.
Status
The
Novel Coronavirus (2019-nCoV) originating from Wuhan, China, has now spread to 27 countries and territories worldwide, with 17387 confirmed cases and 362 deaths (median
age45, range 2-74, predominately males 71%, deaths more in comorbid cases, Just like SARS, it mostly do not affect
children 15 years or less of age).
Countries and territories that have confirmed cases: Thailand,
Japan, Hong Kong, Singapore, Taiwan, Australia, Malaysia, Macau, Russia,
France, the United States, South Korea, Germany, the United Arab Emirates,
Canada, Britain, Vietnam, Italy, India, the Philippines, Nepal, Cambodia, Sri
Lanka, Finland, Sweden and Spain.
Cases
recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United
States involved patients who had not been to China.
It’s not new
Every decade a zoonotic
coronavirus crosses species to infect human populations and in this decade, we
have a virus, provisionally called 2019-nCoV, first identified in Wuhan, China,
in persons exposed to a seafood or wet market in Mid December 2019
CORONA: Crown or Coronary artery
Virus has an RNA core and belongs to
the corona virus family. ‘corona’ means crown or the halo surrounding the sun.
The arteries supplying oxygen to the heart are also called coronary arteries,
because the heart is considered the crown. In electron microscope, it is round
in shape with spikes poking out from its periphery.
The three deadly human respiratory
coronaviruses viruses so far
1.
Severe
acute respiratory syndrome coronavirus [SARS-CoV]
2.
Middle
East respiratory syndrome coronavirus [MERS-CoV])
3.
2019-nCoV:
The virus is 75 to 80% identical to the SARS-CoV
The case fatality is lower than
SARS, MERS and EBOLA
2019 nCoV mortality rate is 2% ( earlier
thought to be 3%) compared to MERS 34%, SARS (out of 5327 cases) 10%, Ebola
50%, Small Pox 30-40%, Measles 10-15% developing countries, Polio 2-5% children
and 15-30% adults, Diphtheria 5-10%, Whooping cough 4% infants < 1yr, 1%
children < 4 years AND Swine flu < 0.1-4 %.
Once the province Hubei (where the epicenter Wuhan is
situated) is removed from the calculation, the national (China) mortality rate
drops to 0.3%. Within the Hubei province, the mortality rate is about 1% when
excluding the city of Wuhan (where it is 5.5%).
Role of CMAAO and other Medical Associations
All countries should be prepared for
containment, including active surveillance, early detection,
isolation and case management, contact tracing and prevention of onward
spread of the virus and to share full data with WHO. All countries
are legally required to share information with WHO under
the IHR.
Any detection of 2019-nCoV in an animal (including
information about the species, diagnostic tests, and relevant epidemiological
information) should be reported to the World Organization for Animal
Health (OIE) as an emerging disease.
All countries should emphasise on reducing human
infection, prevention of secondary transmission and international spread.
Three is no travel or trade restriction based on
the current information available. All
countries must inform WHO about any travel measures taken.
Countries are cautioned against actions that promote stigma or discrimination,
in line with the principles of Article 3 of the IHR.
Its Zoonotic but It is unlikely to spread through seafood in India
It is closely related to several
bat coronaviruses. Bats are the primary reservoir for the virus. SARS-CoV was
transmitted to humans from exotic animals in wet markets, whereas MERS-CoV is
transmitted from camels to humans. In both cases, the ancestral hosts were
probably bats.
The virus has been traced to snakes in China, so, it is
unlikely to spread in India through sea food. Snakes often hunt for bats in
wild. Reports indicate that snakes were sold in the local seafood market in
Wuhan, raising the possibility that the 2019-nCoV might have jumped from the
host species - bats - to snakes and then to humans at the beginning of the
outbreak. However, it remains a mystery as to how the virus could adapt to both
the cold-blooded and warm-blooded hosts.
It is more infectious to humans
Notably, 2019-nCoV grows better in
primary human airway epithelial cells than in standard tissue-culture cells,
unlike SARS-CoV or MERS-CoV. It is likely that 2019-nCoV will behave more like
SARS-CoV.
Human to Human infection
Both SARS-CoV and MERS-CoV infect
intrapulmonary epithelial cells more than cells of the upper airways. Consequently,
transmission occurs primarily from patients with recognized illness and not
from patients with mild, nonspecific signs. However NEJM has reported a case of 2019-nCoV infection acquired
outside of Asia in which transmission appears to have occurred during the
incubation period in the index patient.
It appears that 2019-nCoV uses the
same cellular receptor as SARS-CoV (human angiotensin-converting enzyme 2
[hACE2]), so transmission is expected only after signs of lower
respiratory tract disease develop.
The paramount
reason for breathless is the fact that this new virus attacks the lungs and not
just the throat. Patients so far have not presented with a sore throat, the
reason being that the 2019-nCoV launches an attack at the intraepithelial cells
of lung tissue.
It’s predominantly a large droplet infection
Transmission of 2019-nCoV probably
occurs by means of large droplets and contact and less so by
means of aerosols and fomites, on the basis of experience with SARS-CoV and
MERS-CoV. In lab we need minimum BSL 3 ( or BSL 4 facilities) to prevent
transmission.
The
incubation period
Up to 2 weeks, according to WHO. Mean 5.5 days
Symptoms
One-third landed up
in the intensive care unit; and as many as 15% of these succumbed to the
infection. Almost all patients presented with fever, more than two-thirds had
cough and almost 50% suffered from weakness or muscle ache. More than half
complained of shortness of breath.
2019-nCoV not
unlike other virus disease presents with low white cells and reduction in
lymphocyte count, and raised liver transaminase levels.
Most infected patients experience milder symptoms,
but about 1 in 5 people have severe illness, including pneumonia and
respiratory failure.
Drugs
There
is no proven antiviral treatment. A combination of lopinavir and ritonavir did
show some promise in patients with SARS, but this was in the lab and not in
humans. A randomised study is being done in Saudi Arabia in patients with MERS;
a combination of lopinavir, ritonavir and recombinant interferon beta-1b versus
placebo; the results are awaited.
Scientists in Australia have reportedly recreated a
lab-grown version of coronavirus. The breakthrough would help researchers
around the world as they race to develop a vaccine and detection tests.
Chloroquine, which has
potent antiviral activity against the SARS-CoV, has been shown to have similar
activity against HCoV-229E in cultured cells and against HCoV-OC43 both in
cultured cells and in a mouse model. However, there have been no studies of efficacy
in humans.
PVP-I mouthwashes and gargles significantly reduce
viral load in the oral cavity and the oropharynx. The importance of PVP-I has
been emphasised by its inclusion in the World Health Organization’s list of
essential medicines, and high potency for virucidal activity has been observed
against viruses of significant global concern, including hepatitis A and
influenza, as well as the Middle-East Respiratory Syndrome and Sudden Acute
Respiratory Syndrome coronaviruses.
Universal droplets precautions the
answer
1.
Quarantining
for two weeks
2.
Timely
diagnosis
3.
Strict
adherence to universal precautions
·
Wash your hands often with soap and water for at least 20 seconds. If
soap and water are not available, use an alcohol-based hand sanitizer.
·
Avoid touching your eyes, nose, and mouth with unwashed hands.
·
Avoid close contact with people who are sick.
·
Stay home when you are sick.
·
Cover your cough or sneeze with a tissue, then throw the tissue in the
trash.
·
Clean and disinfect frequently touched objects and surfaces.
These are everyday
habits that can help prevent the spread of several viruses!
Travel
1.
Requires
contact of ten minutes within a distance of six feet
2.
The
virus can remain alive on any surface for 3-12 hours
3. Choosing a
window seat and staying put clearly lowers your likelihood of encountering an
infectious disease.
Contagiousness
The reproduction
number—R0 or “r naught”—simply refers to the number of additional people that
an infected person typically makes sick.
A more recent study is indicating a Ro as high as 4.08.
This value substantially exceeds WHO's estimate (made on Jan. 23) of between
1.4 and 2.5], and is also higher than
recent estimates between 3.6 and 4.0 and between 2.24 to 3.58 . Preliminary
studies had estimated Ro to be between 1.5
and 3.5. Based on
these numbers, on average every case of the Novel Coronavirus would create 3 to
4 new cases. An outbreak with a reproductive number of below 1 will gradually
disappear. The Ro for the common flu is 1.3 and for SARS it was 2.0.
Evacuation
Tokyo,
Japan, India have evacuated their citizens trapped in China afrected areas
Coronavirus:
Mass Quarantine May Spark Irrational Fear, Anxiety, Stigma
Comparisons:
- Every year an estimated
290,000 to 650,000 people die in the world due to complications from
seasonal influenza (flu) viruses. This figure corresponds to 795 to
1,781 deaths per day due to the seasonal flu.
- SARS (Nov. 2002 - Jul.
2003): was a coronavirus that originated from Beijing, China, spread to 29
countries, with 8,096 people infected and 774 deaths (with a fatality rate
of 9.6%). Considering that SARS ended up infecting 5,237 people in
mainland China, Wuhan Coronavirus surpassed SARS on January 29, 2020, when
Chinese officials confirmed 5,974 cases of the novel coronavirus
(2019-nCoV). One day later, on January 30, 2020 the novel coronavirus
cases surpassed even the 8,096 cases worldwide representing the final SARS
count in 2003.
- MERS (2012) killed 858
people out of the 2,494 infected (with a fatality rate of 34.4%).
PMO Suggestions
17th Jan: India at threat of
Corona. Advisory should be issued (18th Indian govt issues travel
advisory as China's mysterious 'Coronavirus' spread in other countries)
22nd Jan: Still not
being declared to be a notifiable disease, N 95 to be included in the list of
essential drugs and prise capped, Oseltamivir, should also be prise capped, air flights
should have available air masks for all passengers, not declaring flu like
symptoms while boarding or landing should be a punishable offence ( 23rd
India advisory to airports)
24th: Inter Ministerial
Committee needs to be formed on Corona Virus ( PMO took a meeting on 24th
evening)
25th Jan: Indian
government should pay for Indians affected with the virus in China
26 Jan: Need of National droplet
Infection Control program, Policy to ban export of face masks, policy to
evacuate Indians from China affected areas, Time to collaborate on Nosode
therapy
27: Anti fever drugs at airports
should be taken
28: Do research on Nosodes
29:
Closure of live markets
30:
Paid flu leave, mask at public places
31:
Resp hygiene advisory schools, Pan India task force
1st
feb: Disaster Budget
Confirmed Cases and
Deaths by Country and Territory
(Affecting 27 countries and
territories)
Country
|
Cases
|
Deaths
|
Region
|
China
|
17,206
|
361
|
Asia
|
Japan
|
20
|
0
|
Asia
|
Thailand
|
19
|
0
|
Asia
|
Singapore
|
18
|
0
|
Asia
|
South Korea
|
15
|
0
|
Asia
|
Hong Kong
|
14
|
0
|
Asia
|
Australia
|
12
|
0
|
Australia/Oceania
|
Germany
|
10
|
0
|
Europe
|
Taiwan
|
10
|
0
|
Asia
|
United States
|
9
|
0
|
North America
|
Malaysia
|
8
|
0
|
Asia
|
Macao
|
8
|
0
|
Asia
|
Vietnam
|
7
|
0
|
Asia
|
France
|
6
|
0
|
Europe
|
United Arab Emirates
|
5
|
0
|
Asia
|
Canada
|
4
|
0
|
North America
|
Philippines
|
2
|
1
|
Asia
|
Italy
|
2
|
0
|
Europe
|
India
|
2
|
0
|
Asia
|
United Kingdom
|
2
|
0
|
Europe
|
Russia
|
2
|
0
|
Europe
|
Nepal
|
1
|
0
|
Asia
|
Finland
|
1
|
0
|
Europe
|
Sweden
|
1
|
0
|
Europe
|
Sri Lanka
|
1
|
0
|
Asia
|
Cambodia
|
1
|
0
|
Asia
|
Spain
|
1
|
0
|
Europe
|
Total Deaths of Novel Coronavirus
(2019-nCoV)
Date
|
Total
Deaths |
Change
in Total |
Change
in
Total (%) |
Feb. 2
|
362
|
58
|
19%
|
Feb. 1
|
304
|
45
|
17%
|
Jan. 31
|
259
|
46
|
22%
|
Jan. 30
|
213
|
43
|
25%
|
Jan. 29
|
170
|
38
|
29%
|
Jan. 28
|
132
|
26
|
25%
|
Jan. 27
|
106
|
26
|
33%
|
Jan. 26
|
80
|
24
|
43%
|
Jan. 25
|
56
|
15
|
37%
|
Jan. 24
|
41
|
16
|
64%
|
Jan. 23
|
25
|
8
|
47%
|
Daily Deaths of Novel Coronavirus
(2019-nCoV)
Date
|
Daily
Deaths |
Change
in Daily |
Change
in
Daily (%) |
Feb. 2
|
58
|
13
|
29%
|
Feb. 1
|
45
|
-1
|
-2%
|
Jan. 31
|
46
|
3
|
7%
|
Jan. 30
|
43
|
5
|
13%
|
Jan. 29
|
38
|
12
|
46%
|
Jan. 28
|
26
|
0
|
0%
|
Jan. 27
|
26
|
2
|
8%
|
Jan. 26
|
24
|
9
|
60%
|
Jan. 25
|
15
|
-1
|
-6%
|
Jan. 24
|
16
|
8
|
100%
|
Jan. 23
|
8
|
0
|
0%
|
No comments:
Post a Comment